<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>WORL | Cannon Burke | Activity</title>
	<link>https://www.worl.com/stockbush4/activity/</link>
	<atom:link href="https://www.worl.com/stockbush4/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Cannon Burke.</description>
	<lastBuildDate>Sat, 04 Jul 2026 16:13:57 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">dd490f77e6aee34f3bfc81e33fe36fb5</guid>
				<title>Cannon Burke posted an update: The use of anabolic-steroid cycles has been a subject of [&#133;]</title>
				<link>https://www.worl.com/activity/p/14318/</link>
				<pubDate>Thu, 02 Oct 2025 11:00:06 +0000</pubDate>

									<content:encoded><![CDATA[<p>The use of anabolic-steroid cycles has been a subject of interest for bodybuilders and athletes looking to enhance muscle mass, strength, and overall physique. One of the most popular oral steroid stacks involves Winstrol (Stanozolol) and Anavar (Oxandrolone). This combination is chosen for its relatively low androgenic side-effects while still&hellip;<span class="activity-read-more" id="activity-read-more-14318"><a href="https://www.worl.com/activity/p/14318/" rel="nofollow ugc">Read more</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">8b598696c6e99c46ff766800302b0cae</guid>
				<title>Cannon Burke became a registered member</title>
				<link>https://www.worl.com/activity/p/14121/</link>
				<pubDate>Thu, 02 Oct 2025 08:08:24 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>